Featuring perspectives from Prof Nicolas
Girard, Dr Jonathan Goldman, Dr Pasi A Jänne, Dr Suresh S
Ramalingam, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr
Yu, including the following topics:
Introduction (0:00)
Evolving First-Line Treatment for Metastatic EGFR
Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Dr Yu
(1:47)
EGFR-Targeted Approaches for Relapsed EGFR-Mutant NSCLC;
Strategies to Facilitate Delivery of Recently Approved Agents — Dr
Sabari (23:48)
Potential Utility of TROP2-Targeted Therapy in the Management
of EGFR-Mutant NSCLC — Dr Ramalingam (45:16)
Contemporary Care for Patients with Nonmetastatic EGFR-Mutant
NSCLC — Dr Goldman (1:03:56)
Current and Future Management of EGFR Exon 20 Mutation-Positive
NSCLC — Prof Girard (1:24:40)
Emerging Role of HER3-Targeted Therapy in the Management of
EGFR-Mutant NSCLC — Dr Jänne (1:43:46)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.